Bart van der Wiel, MD PhD

Pathologist
Netherlands Cancer Institute - Antoni van Leeuwenhoek, United States

Presentation(s):

• 59: Surgical considerations for resecting the index lymph node after neo-adjuvant checkpoint inhibitors: lessons learned from the PRADO trial

  Friday, March 22, 2024
  2:02pm – 2:14pm ET